Emergence of hepatitis C virus resistance associated variants in patients failing direct acting antivirals by ultra-deep sequencing

被引:0
|
作者
Nguyen, T. [1 ,2 ]
Akhavan, S. [3 ]
Caby, F. [4 ]
Bonyhay, L. [5 ]
Larrouy, L. [6 ]
Gervais, A. [7 ]
Lebray, P. [5 ]
Poynard, T. [8 ]
Calmus, Y. [9 ]
Simon, A. [10 ]
Valantin, M. -A. [4 ]
Calvez, V. [1 ,2 ]
Marcelin, A. -G. [1 ,2 ]
Todesco, E. [1 ,2 ]
机构
[1] Inst Pierre Louis Epidemiol, Paris, France
[2] UPMC Univ Paris 06, Sorbonne Univ, Paris, France
[3] Hop La Pitie Salpetriere, AP HP, Dept Virol, Paris, France
[4] Hop La Pitie Salpetriere, AP HP, Infect Dis Dept, Paris, France
[5] Hop La Pitie Salpetriere, Serv Hepatogastroenterol, Paris, France
[6] Univ Paris Diderot, Hop Bichat, Sorbonne Paris Cite, Lab Virol,AP HP,INSERM,IAME,UMR 1137, Paris, France
[7] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France
[8] Univ Paris 06, Grp Hosp Pitie Salpetriere, Inst Cardiometab & Nutr ICAN, France Sorbonne Univ,UPMC,AP HP,INSERM,UMR S 938, Paris, France
[9] UPMC Paris VI, Hop Pitie Salpetriere, AP HP, Unite Med Transplantat Hepat,Hepatogastroenterol, Blvd Hop, Paris, France
[10] Hop La Pitie Salpetriere, AP HP, Dept Med Interne & Immunol Clin, Paris, France
关键词
D O I
10.1016/S0168-8278(18)30751-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-310
引用
收藏
页码:S268 / S268
页数:1
相关论文
共 50 条
  • [1] A Translational Study of Resistance Emergence Using Sequential Direct-Acting Antiviral Agents for Hepatitis C Using Ultra-Deep Sequencing
    Abe, Hiromi
    Hayes, C. Nelson
    Hiraga, Nobuhiko
    Imamura, Michio
    Tsuge, Masataka
    Miki, Daiki
    Takahashi, Shoichi
    Ochi, Hidenori
    Chayama, Kazuaki
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (09): : 1464 - 1472
  • [2] Hepatitis C virus resistance to the new direct-acting antivirals
    Esposito, Isabella
    Trinks, Julieta
    Soriano, Vicente
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1197 - 1209
  • [3] Emergence of resistant variants detected by ultra-deep sequencing after asunaprevir and daclatasvir combination therapy in patients infected with hepatitis C virus genotype 1
    Kosaka, K.
    Imamura, M.
    Hayes, C. N.
    Abe, H.
    Hiraga, N.
    Yoshimi, S.
    Murakami, E.
    Kawaoka, T.
    Tsuge, M.
    Aikata, H.
    Miki, D.
    Ochi, H.
    Matsui, H.
    Kanai, A.
    Inaba, T.
    Chayama, K.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (02) : 158 - 165
  • [4] Characterisation of resistance associated substitutions in direct acting antivirals treatment naive patients with genotype 3 hepatitis C virus
    Smith, D. A.
    Magri, A.
    Bonsall, D.
    Ansari, M. A.
    Ip, C.
    Trebes, A.
    Brown, A.
    Piazza, P.
    Bowden, R.
    Klenerman, P.
    Simmonds, P.
    Barnes, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S276 - S277
  • [5] Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals
    Mushtaq, Saima
    Hashmi, Asraf Hussain
    Khan, Amjad
    Kazmi, Syed Muhammad Asad Raza
    Manzoor, Sobia
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [6] Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis
    Fabrizi, Fabrizio
    Donato, Francesca M.
    Messa, Piergiorgio
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2017, 40 (10): : 531 - 541
  • [7] Effects of Direct-Acting Antivirals on Insulin Resistance in Hepatitis C Patients
    Moon, Jooyoung
    Moon, Hanna
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2021, 116 : 46 - 46
  • [8] Evolution Of Cirrhotic Patients With Hepatitis C Virus Treated With Direct Acting Antivirals
    Murcia, Oscar
    Carnicer, Fernando
    Gomez-Escolar, Laura
    Miralles, Cayetano
    Grino, Maria Pilar
    Barquero Martin, Claudia
    Pascual, Sonia
    HEPATOLOGY, 2017, 66 : 768A - 768A
  • [9] Enhanced fitness of hepatitis C virus increases resistance to direct-acting antivirals
    Soni, Shalini
    Singh, Deepak
    Aggarwal, Rakesh
    Veerapu, Naga Suresh
    JOURNAL OF GENERAL VIROLOGY, 2022, 103 (02):
  • [10] Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing
    Thuy Nguyen
    Akhavan, Sepideh
    Caby, Fabienne
    Bonyhay, Luminita
    Larrouy, Lucile
    Gervais, Anne
    Lebray, Pascal
    Poynard, Thierry
    Calmus, Yvon
    Simon, Anne
    Valantin, Marc-Antoine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    Todesco, Eve
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2019, 53 (01) : 80 - 83